Curing Versus Managing CLL

Clinical Pearls

Adrian Wiestner, MD, PhD, senior investigator, National Institutes of Health, discusses curing or managing patients with chronic lymphocytic leukemia (CLL).

• The question remains as to whether CLL can be cured or if it should be managed over the long term.
• This answer depends on the age and comorbidities of the patient.
• The safety of CLL drugs over the course of many years in unknown.

<<<

Go back to the ASH conference page